Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,611.40
(
0.41%
)
US TECH 100
29,758.40
(
0.77%
)
Dow Jones
51,050.01
(
0.03%
)
Brent Oil
94.61
(
3.56%
)
Bitcoin
71,579.32
(
-2.69%
)
News Focus
News Focus
Post# of 57997
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

neuroinv

Send PM Follow Ignore
Followers 32
Posts 2552
Boards Moderated 0
Alias Born 07/16/2006

neuroinv

Re: haysaw post# 28584

Monday, 09/14/2009 9:29:08 AM

Monday, September 14, 2009 9:29:08 AM

Post# of 57997
OK. I was confused because they were already well past IND stage with CX-717, having run their Phase I and Phase IIa studies. But you were referring to the amount potentially receivable had Laughren lifted the clinical hold on CX-717. Not an important point, I just wanted to make sure you weren't referring to the next actual 'approval' stage, NDA approval.

NeuroInvestment
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today